GUGGULU – A POTENT ANTI - INFLAMMATORY AGENT
Journal Title: World Journal of Pharmaceutical and life sciences - Year 2018, Vol 4, Issue 1
Abstract
Guggulu, a herb, the useful part of which is resin is one of the commonest content of herbal or herbomineral combinations mentioned in ayurvedic classics. A thoughtful insight of literature reveals that this resin possess pharmacological properties which are comparable to modern anti- inflammatory drugs. In the present conceptual study, literature review of Guggulu is presented with the explanation of mechanism of action as an potent anti- inflammatory agent.
Authors and Affiliations
Dr. Durga Katarmal
Keywords
Related Articles
- EP ID EP650277
- DOI -
- Views 121
- Downloads 0
ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND DETERMINATION OF ARTESUNATE IN PHARMACEUTICAL TABLET FORMULATIONS
Resistance to conventional antimalarials triggered off new policies to circumvent the devastating consequences of malaria especially in the trans-Saharan Africa. The use of artemisinin-based combinations as first line dr...
ROLE OF ERANDADI TAILA IN THE MANAGEMENT OF KARNA NADA-A CONCEPTUAL STUDY
Karna Nada, a hearing disorder mentioned in Sushruta Samhita can be co-related with tinnitus on the basis of signs and symptoms. As per the literature, Karna Nada is Vata Dosha predominant disorder along with Avarana of...
AYURVEDIC APPROACH IN THE MANAGEMENT OF ANIDRA W.S.R TO INSOMNIA: A REVIEW ARTICLE
Sleep is very important phenomenon to organisms without which life is not possible. Good sleep is the best indicator of good health. It affects adversely if not enjoyed in a rightful manner leading to sleep disorders. Ps...
KAP (KNOWLEDGE, ATTITUDE AND PERCEPTION ) STUDY OF BREAST FEEDING MOTHERS OF BABIES AGED ≤ 6 MONTHS
Background: Although exclusive breast feeding is universally accepted as the best feeding for the babies during first 6 months of life, only 40 % of women do breast feed their babies for some wrong perceptions and miscon...
DRUG DISCOVERY CHALLENGES
Low productivity, rising R&D costs, dissipating proprietary products and dwindling pipelines are driving the pharmaceutical industry to unprecedented challenges and scrutiny. In this presentation we reflect on the curren...